Scottish Medical Journal最新文献

{"title":"Relocation, laser dusting and suction (RELOADUS): An international collaborative observational study for laser management to prevent strictures of symptomatic impacted upper ureteric stones.","authors":"Syed Mustafa Shah, Zaara Nabi, Nipun Bansal, Waheed Uz Zaman, Mohammed Hidayat Khan, Zubda Malik, Taher Marry, Jose Antonio Sanudo Campos, Ghulam Nabi","doi":"10.1177/00369330261480995","DOIUrl":"https://doi.org/10.1177/00369330261480995","url":null,"abstract":"<p><p>BackgroundUreteric stricture formation following ureteroscopy and laser management of stones is known.ObjectiveTo evaluate the feasibility, safety, stone clearance outcomes and rate of upper ureteric stricture formation after implementation of the Relocation, laser dusting and suction (RELOADUS) technique for the endoscopic management of impacted upper ureteric stones.MethodsThis is an international collaborative study recruiting 80 consecutive patients with impacted upper ureteric stones with a mean size of 7.2 mm ± 4.2. Patients were managed by relocation of impacted upper ureter stones, laser dusting and suction at multiple centres (intervention group). A control group (<i>n</i> = 80) was identified from the databases of these centres to assess the outcome. Primary outcome of the study was the rate of ureteric stricture formation on follow-up.Key Findings and LimitationsAt a mean follow-up of 12.2 ± 5.9 months, the observed rate of upper ureteric stricture was lower in the intervention group than in the control group, although this difference did not reach statistical significance (1/80, 1.25% vs. 4/80, 5%; <i>p</i> = 0.367). Similarly, a higher rate of residual stone fragments was seen on follow-up imaging at 3 months in the control group (<i>p</i> = 0.002). There were no differences in the duration of procedure or follow-up unscheduled admissions between the groups.InterventionRELOADUS is a technique where impacted upper ureteric stones are relocated into renal pelvis, dusted using laser and then suction applied to achieve complete clearance.ConclusionsThe RELOADUS technique appears to be a feasible and safe management strategy for impacted upper ureteric stones. By relocating impacted stones from the narrow ureter to the more capacious renal pelvis and utilising laser dusting with suction, the approach achieved high stone-free rates while aiming to reduce laser activation and instrumentation within the ureter. Larger prospective studies are required to confirm its effect on ureteric stricture formation.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330261480995"},"PeriodicalIF":1.3,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149196233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of olanzapine on body weight, body mass index, and waist circumference: A time- and dose-response meta-analysis of randomized controlled trials.","authors":"Ahmed Abu-Zaid, Reem Alyoubi, Huda Yahya Alyahyawi, Saleh Ak Saleh, Heba M Adly, Khaled Alabduljabbar, Saeed Baradwan, Badr Mohammed Bayazeed, Syed O Ahmad","doi":"10.1177/00369330261487638","DOIUrl":"https://doi.org/10.1177/00369330261487638","url":null,"abstract":"<p><p>AimThis systematic review and meta-analysis evaluated the effects of olanzapine, a second-generation antipsychotic, on body weight (BW), body mass index (BMI), and waist circumference (WC), and examined the influence of dose and treatment duration.MethodsPubMed, Embase, Scopus, and Web of Science were searched through June 2025 for randomized controlled trials (RCTs) comparing olanzapine with placebo in adults. Eligible studies reported baseline and follow-up data for BW, BMI, or WC. Pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated using random-effects models. Subgroup and dose-response analyses were performed.ResultsFifteen RCTs comprising 18 study arms were included. Olanzapine significantly increased BW (16 arms; WMD: 1.72 kg; 95% CI: 0.55-2.88; <i>p</i> = 0.004), BMI (four arms; WMD: 0.84 kg/m²; 95% CI: 0.24-1.43; <i>p</i> = 0.005), and WC (two arms; WMD: 5.79 cm; 95% CI: 1.85-9.73; <i>p</i> = 0.004) versus placebo. Greater effects were observed with doses ≥10 mg/day and treatment durations ≤12 weeks. Participants with baseline BMI <25 kg/m² experienced greater weight gain. Dose-response analysis demonstrated increasing weight gain at doses >5 mg/day.ConclusionOlanzapine significantly increases BW, BMI, and central adiposity, particularly at higher doses and during early treatment, highlighting the importance of dose optimization and metabolic monitoring.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330261487638"},"PeriodicalIF":1.3,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148991268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Litigation in obstetrics and gynaecology in the UK National Health Service over a 17-year period: An analysis of the trends, costs and causes.","authors":"Anoushka Umranikar, Abhinav Tiwari, Bhaskar K Somani","doi":"10.1177/00369330261485383","DOIUrl":"https://doi.org/10.1177/00369330261485383","url":null,"abstract":"<p><p>IntroductionObstetrics and Gynaecology (O&G) is one of the most litigious medical specialities. This study aimed to analyse the trends and reasons for litigation claims in O&G within the UK National Health Service (NHS) over a 17-year period.MethodsUsing data requested from NHS Resolution under the Freedom of Information Act 2000, an analysis was carried out which included the total number and rate of litigation claims in O&G, the number of these claims that were successful (settled or closed), the damages paid due to successful claims, and the reasons for successful claims between financial years 2006/07 and 2023/24.Results29,129 litigation claims were made in the speciality of O&G between 2006/07 and 2023/24. 66.0% (19,239/29,129) were in Obstetrics, and 34.0% (9890/29,129) were in Gynaecology. 60.8% (17,698/29,129) of O&G claims were successful. The rate of claims in Obstetrics increased per 1000 births (1.1 in 2006 to 2.5 in 2023/24) from the start to the end of the study period. The primary causes for successful claims in Obstetrics included failure/delay of treatment (16.5%, 1943/11,806), failure/delay in diagnosis (8.8%, 1042/11,806) and failure to make response to abnormal fetal heart rate (7.9%, 931/11,806). For Gynaecology, the primary causes were failure/delay of treatment (15.2%, 898/5892), intra-operative problems (15.1%, 888/5892) and failure/delay in diagnosis (12.5%, 735/5892). Never events accounted for 9.3% (790/17,698) of successful claims in O&G.ConclusionO&G has become an increasingly litigious speciality over the last two decades. Although delay in treatment or diagnosis accounted for the highest proportion of successful claims, never events accounted for just under 10% of cases. More work can be done to reduce the risk of these adverse events.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330261485383"},"PeriodicalIF":1.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-world impact of implementing a point-of-care high-sensitivity troponin pathway on emergency department flow.","authors":"Faheem Ahmad, Usmaan Razzaq, Vaishnavi Muthukrishnan, Angela Burns, Katriona Brooksbank, Louise Boughen, Ian Godber, Andrew Saunders","doi":"10.1177/00369330261481425","DOIUrl":"https://doi.org/10.1177/00369330261481425","url":null,"abstract":"<p><p>BackgroundPoint-of-care (POC) high-sensitivity cardiac troponin I (hs-cTnI) testing can reduce diagnostic turnaround in the emergency department (ED), but real-world operational data remain mixed.MethodsObservational before-after service evaluation at a high-volume UK tertiary ED (Queen Elizabeth University Hospital, Glasgow; ∼200,000 attendances/year). On 12 November 2025 a new chest-pain pathway combined bedside POC hs-cTnI (Abbott i-STAT Alinity) with a reduction in the serial-sampling interval from 0-3 to 0-2 hours, via an immediate hard switch; disposition thresholds were unchanged. The primary outcome was ED length of stay (LOS); interrupted time series (ITS) assessed the temporal association with implementation.ResultsOf 1381 attendances (718 pre- and 663 post-implementation), median LOS fell from 382 to 319 minutes (-63; p < 0.001), and from 510 to 335 minutes among serial-testing patients (-175; Wilcoxon p < 0.001). Four-hour breach fell from 78.8% to 67.3% overall (-11.6 percentage points; 95% confidence interval (CI) -16.2 to -6.9) and from 95.7% to 72.7% in serial testers. ITS showed an immediate level change at go-live (-144 minutes; p < 0.001); estimated capacity released ∼51 bed-hours/day.ConclusionImplementing this POC-based pathway was temporally associated with immediate reductions in ED LOS and 4-hour breach, greatest among serial-testing patients. Benefit is likely greatest where overcrowding and slow laboratory turnaround coexist.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330261481425"},"PeriodicalIF":1.3,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148888508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of quantitative faecal immunochemical test (qFIT) in patients presenting with per-rectal bleeding: A cohort study from a colorectal unit in Scotland.","authors":"Muhammad Bilal Akbar, Wai Wai Win Mar, Abdullahi Mohammed, Yousef Abduldaiem, Priyanka Bhandari, Ross Dean Dolan","doi":"10.1177/00369330261477243","DOIUrl":"https://doi.org/10.1177/00369330261477243","url":null,"abstract":"<p><p>Background and AimsThe quantitative faecal immunochemical test (qFIT) is established for triaging patients with lower gastrointestinal symptoms, but its utility in those with per-rectal bleeding (PRB) requires further validation. This study aimed to: (1) evaluate qFIT as a first-line investigation for ruling out colorectal cancer (CRC) in patients with PRB; (2) assess the diagnostic yield of qFIT across different quantitative ranges; and (3) determine the positive predictive values and negative predictive values (NPVs) for CRC and clinically relevant benign bowel pathologies (BBPs).MethodsA cohort analytical study was conducted (May 2022-September 2023) involving 203 patients referred via the two-week wait pathway with suspected CRC. Patients were stratified into four groups based on the presence of PRB and qFIT result (positive: ≥10 µg Hb/g). Diagnostic outcomes (CRC and BBP) were confirmed via colonoscopy, imaging, cross-sectional imaging, and histopathology where applicable.ResultsOf 203 patients, 76 (37.4%) presented with PRB. In the PRB group, 53 had a positive qFIT (Group 1), and 23 had a negative qFIT (Group 2). CRC was detected in 5 out of 53 (9.4%) in Group 1 and 0 out of 23 (0%) in Group 2, yielding an NPV of 100% (95% confidence interval (CI) 85.2%-100.0%) for CRC in PRB patients. Among the 127 patients without PRB, CRC was found in 13 out of 88 (14.8%) with a positive qFIT (Group 3) and 1 out of 39 (2.6%) with a negative qFIT (Group 4). In patients without PRB, qFIT positivity showed a non-significant trend towards higher odds of CRC (odds ratio (OR) 6.59, 95% CI 0.82-53.0; <i>p</i> = 0.07). CRC prevalence increased significantly with rising qFIT values, with patients having qFIT >400 µg/g demonstrating higher odds of CRC than those with qFIT 10-150 µg/g (OR 22.0, 95% CI 3.56-136.1; <i>p</i> = 0.001). The incidence of BBP remained high across all groups, including 56.5% of qFIT-negative patients with PRB.ConclusionIn this cohort, qFIT demonstrated a high NPV for CRC in patients presenting with PRB. A negative qFIT in patients presenting with PRB may support risk stratification and could help reduce unnecessary colonoscopy in selected cases, but larger prospective studies are needed before firm de-escalation recommendations can be made. Patients without PRB but with high qFIT levels (>400 µg/g) should be prioritised for urgent investigation, given the high probability of CRC.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330261477243"},"PeriodicalIF":1.3,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148832139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extracorporeal membrane oxygenation use in trauma and emergency care: An update.","authors":"Canan Akman, Asli Bahar Ucar, Gokhan Yilmaz, Asim Bedri Erdem, Mehmet Unaldi, Bilgen Ozkaya, Ozgur Karcioglu","doi":"10.1177/00369330261477248","DOIUrl":"https://doi.org/10.1177/00369330261477248","url":null,"abstract":"<p><p>Extracorporeal membrane oxygenation (ECMO) has a life-saving role in trauma management, with particular relevance to patients with acute respiratory failure. This narrative review describes the current evidence on the use of ECMO in the resuscitation of major trauma victims presenting with acute respiratory distress syndrome, cardiogenic shock, poisoning, burns, and traumatic brain injury, and highlights recent advances in the field. A comprehensive literature search of PubMed and EMBASE was performed for articles, using the MeSH/keywords. Over the past decade, ECMO has been increasingly applied for trauma management, encompassing both venovenous (VV) and venoarterial (VA) modes. VV-ECMO is primarily utilized in hypoxic respiratory failure following thoracic trauma and is associated with improved in-hospital mortality and higher discharge survival compared to conventional mechanical ventilation. VA-ECMO is reserved for hemodynamic collapse and extracorporeal cardiopulmonary resuscitation, a subset of VA-ECMO used specifically in cardiac arrest. Despite promising outcomes, challenges remain, including anticoagulation management, hemorrhagic complications, and the absence of trauma-specific prognostic models. Emerging applications include ECMO in traumatic brain injury, poisoning, and severe burns. Although ECMO improves outcomes in selected trauma patients, further high-quality studies are needed to define optimal selection criteria and to clarify its role across the spectrum of injuries.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330261477248"},"PeriodicalIF":1.3,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148819464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes among secondary prevention implantable cardioverter-defibrillator recipients aged ≥80 years at time of implant in the West of Scotland: A 7-year retrospective review.","authors":"Aimee H McCoubrey, Roy S Gardner, Simon As Beggs","doi":"10.1177/00369330261467440","DOIUrl":"10.1177/00369330261467440","url":null,"abstract":"<p><p>Introduction and aimsGuidelines recommend secondary prevention implantable cardioverter defibrillator (SP-ICD) therapy after significant ventricular arrhythmia. However, landmark SP-ICD trials enrolled patients with mean ages of 58-65 years. No randomised evidence guides SP-ICD use in patients aged ≥80 years, despite the increasing importance of competing modes of death when assessing benefit. We aimed to describe the patient journey and clinical outcomes of individuals aged ≥80 years receiving an SP-ICD at a single high-volume centre over 7 years.Methods and resultsWe retrospectively reviewed all consecutive device implants at a regional Scottish centre from 2014 to 2021 to identify SP-ICD implantation in patients aged ≥80 years. Clinical data were then obtained from electronic health records. Thirty-eight patients received an SP-ICD. Survival free from ICD deactivation or death at 6 months, 1 year and 2 years was 95%, 84% and 71%, respectively. During follow-up, 21 patients (55%) received appropriate therapy. There was an overall complication rate of 13%. One patient received inappropriate ICD therapy, and five patients (13%) experienced ICD shock storm.ConclusionOctogenarians receiving SP-ICDs experienced frequent appropriate defibrillator therapy and acceptable survival, but complications were common. These findings emphasise patient-centred decision-making and counselling about risks, future therapies and potential device deactivation.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"87-91"},"PeriodicalIF":1.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148437735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving access and reducing patient travel burden through telehealth: A quality improvement report from NHS Scotland.","authors":"Ibrahim Mohammed Fawzi Al-Shahwani, Nawwar Al-Attar","doi":"10.1177/00369330261437040","DOIUrl":"10.1177/00369330261437040","url":null,"abstract":"<p><p>BackgroundPatients attending tertiary healthcare centres often travel long distances for routine outpatient consultations, leading to time loss, financial burden, and reduced access to care. Telehealth offers an opportunity to reduce unnecessary patient travel while maintaining appropriate clinical care.AimTo evaluate the impact of introducing telehealth consultations on patient travel distance, travel time, and estimated fuel costs within a tertiary surgical outpatient service in NHS Scotland.MethodsThis quality improvement project used a single Plan-Do-Study-Act (PDSA) cycle. Between January and April 2025, 50 patients scheduled for routine outpatient interviews were converted from face-to-face to video consultations using an NHS-approved platform (NHS Near Me). Avoided round-trip travel distance was calculated using patient postcodes. Travel time and fuel cost savings were estimated using standardised metrics.ResultsA total of 3014.4 miles of patient travel were avoided, corresponding to an estimated 144.7 h of travel time saved and £452.16 in fuel costs. No consultations required rescheduling due to technical failure. Informal patient feedback indicated high acceptance and satisfaction with telehealth consultations.ConclusionTelehealth substantially reduced patient travel burden for suitable outpatient consultations and improved access to care. Wider adoption of telehealth for routine outpatient interviews within NHS Scotland is feasible and recommended.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"120-122"},"PeriodicalIF":1.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147594269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of inflammation with sex hormones and vitamin D in women: Findings from NHANES (2021-2023).","authors":"Ahmed Abu-Zaid, Saeed Baradwan, Heba M Adly, Saleh A K Saleh, Saud Owaimer Alsehaimi, Hedayah Albelwi, Saad M S Alqarni, Mohammed Ziad Jamjoom, Safa Alabdrabalamir, Mohannad Alsabban, Ahmed Nazer, Osama Alomar, Ismail A Al-Badawi","doi":"10.1177/00369330261457769","DOIUrl":"10.1177/00369330261457769","url":null,"abstract":"<p><p>ObjectiveTo examine associations between systemic inflammation, sex hormones, and vitamin D levels in U.S. women.MethodsA cross-sectional study was conducted using NHANES 2021-2023 data from 3179 women aged 18-80 years. Participants were grouped by high-sensitivity C-reactive protein (hs-CRP) quartiles. Demographic, anthropometric, lifestyle, dietary, and clinical variables were analyzed. Serum biomarkers included hs-CRP, sex hormones, lipid parameters, and 25-hydroxyvitamin D3 (25OHD3). Multivariable linear regression assessed independent associations between hs-CRP and endocrine markers after adjustment for confounders.ResultsWomen in the highest hs-CRP quartile had higher age, body weight, waist circumference, body mass index, and prevalence of hypertension and diabetes than those in the lowest quartile. Higher hs-CRP levels were associated with lower concentrations of 17α-hydroxyprogesterone, androstenedione, anti-Müllerian hormone (AMH), dehydroepiandrosterone sulfate, follicle-stimulating hormone (FSH), sex hormone-binding globulin, and 25OHD3. After adjustment, hs-CRP remained positively associated with AMH (<i>β</i> = 0.212, <i>p</i> = 0.007), estrone (<i>β</i> = 0.142, <i>p</i> = 0.048), low-density lipoprotein cholesterol (<i>β</i> = 0.241, <i>p</i> = 0.002), and total cholesterol (<i>β</i> = 0.224, <i>p</i> = 0.001), and inversely associated with FSH (<i>β</i> = -0.194, <i>p</i> = 0.039) and luteinizing hormone (<i>β</i> = -0.191, <i>p</i> = 0.019).ConclusionSystemic inflammation was associated with reproductive hormones and lipid profiles, while many associations weakened after adjustment for adiposity. These findings highlight complex links between inflammation, endocrine function, and cardiometabolic health, influenced by obesity-related factors.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"92-101"},"PeriodicalIF":1.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148176767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Horizon scanning of healthcare technology and future of Medicine: Secondary prevention, tele-health, large databases, radiogenomics and intelligent clinical decision-making.","authors":"Ghulam Nabi","doi":"10.1177/00369330261475419","DOIUrl":"10.1177/00369330261475419","url":null,"abstract":"","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"71 3","pages":"85-86"},"PeriodicalIF":1.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148722138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}